Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study

<p>Abstract</p> <p>Background</p> <p>Although neuroimaging techniques have provided insights into the function of brain regions involved in Trigeminal Neuropathic Pain (TNP) in humans, there is little understanding of the molecular mechanisms affected during the course...

Full description

Bibliographic Details
Main Authors: DosSantos Marcos, Martikainen Ilkka, Nascimento Thiago, Love Tiffany M, Deboer Misty, Maslowski Eric C, Monteiro André, Vincent Maurice, Zubieta Jon-Kar, DaSilva Alexandre F
Format: Article
Language:English
Published: SAGE Publishing 2012-09-01
Series:Molecular Pain
Subjects:
Online Access:http://www.molecularpain.com/content/8/1/74
_version_ 1828291438479147008
author DosSantos Marcos
Martikainen Ilkka
Nascimento Thiago
Love Tiffany M
Deboer Misty
Maslowski Eric C
Monteiro André
Vincent Maurice
Zubieta Jon-Kar
DaSilva Alexandre F
author_facet DosSantos Marcos
Martikainen Ilkka
Nascimento Thiago
Love Tiffany M
Deboer Misty
Maslowski Eric C
Monteiro André
Vincent Maurice
Zubieta Jon-Kar
DaSilva Alexandre F
author_sort DosSantos Marcos
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Although neuroimaging techniques have provided insights into the function of brain regions involved in Trigeminal Neuropathic Pain (TNP) in humans, there is little understanding of the molecular mechanisms affected during the course of this disorder. Understanding these processes is crucial to determine the systems involved in the development and persistence of TNP.</p> <p>Findings</p> <p>In this study, we examined the regional μ-opioid receptor (μOR) availability <it>in vivo</it> (non-displaceable binding potential BP<sub>ND</sub>) of TNP patients with positron emission tomography (PET) using the μOR selective radioligand [<sup>11</sup>C]carfentanil. Four TNP patients and eight gender and age-matched healthy controls were examined with PET. Patients with TNP showed reduced μOR BP<sub>ND</sub> in the left nucleus accumbens (NAc), an area known to be involved in pain modulation and reward/aversive behaviors. In addition, the μOR BP<sub>ND</sub> in the NAc was negatively correlated with the McGill sensory and total pain ratings in the TNP patients.</p> <p>Conclusions</p> <p>Our findings give preliminary evidence that the clinical pain in TNP patients can be related to alterations in the endogenous μ-opioid system, rather than only to the peripheral pathology. The decreased availability of μORs found in TNP patients, and its inverse relationship to clinical pain levels, provide insights into the central mechanisms related to this condition. The results also expand our understanding about the impact of chronic pain on the limbic system.</p>
first_indexed 2024-04-13T10:52:56Z
format Article
id doaj.art-fd20ef1cf7b04c008782b47734f48bac
institution Directory Open Access Journal
issn 1744-8069
language English
last_indexed 2024-04-13T10:52:56Z
publishDate 2012-09-01
publisher SAGE Publishing
record_format Article
series Molecular Pain
spelling doaj.art-fd20ef1cf7b04c008782b47734f48bac2022-12-22T02:49:37ZengSAGE PublishingMolecular Pain1744-80692012-09-01817410.1186/1744-8069-8-74Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot studyDosSantos MarcosMartikainen IlkkaNascimento ThiagoLove Tiffany MDeboer MistyMaslowski Eric CMonteiro AndréVincent MauriceZubieta Jon-KarDaSilva Alexandre F<p>Abstract</p> <p>Background</p> <p>Although neuroimaging techniques have provided insights into the function of brain regions involved in Trigeminal Neuropathic Pain (TNP) in humans, there is little understanding of the molecular mechanisms affected during the course of this disorder. Understanding these processes is crucial to determine the systems involved in the development and persistence of TNP.</p> <p>Findings</p> <p>In this study, we examined the regional μ-opioid receptor (μOR) availability <it>in vivo</it> (non-displaceable binding potential BP<sub>ND</sub>) of TNP patients with positron emission tomography (PET) using the μOR selective radioligand [<sup>11</sup>C]carfentanil. Four TNP patients and eight gender and age-matched healthy controls were examined with PET. Patients with TNP showed reduced μOR BP<sub>ND</sub> in the left nucleus accumbens (NAc), an area known to be involved in pain modulation and reward/aversive behaviors. In addition, the μOR BP<sub>ND</sub> in the NAc was negatively correlated with the McGill sensory and total pain ratings in the TNP patients.</p> <p>Conclusions</p> <p>Our findings give preliminary evidence that the clinical pain in TNP patients can be related to alterations in the endogenous μ-opioid system, rather than only to the peripheral pathology. The decreased availability of μORs found in TNP patients, and its inverse relationship to clinical pain levels, provide insights into the central mechanisms related to this condition. The results also expand our understanding about the impact of chronic pain on the limbic system.</p>http://www.molecularpain.com/content/8/1/74Trigeminal Neuropathic PainOpioid systemNeuroplasticityChronic painPositron emission tomography
spellingShingle DosSantos Marcos
Martikainen Ilkka
Nascimento Thiago
Love Tiffany M
Deboer Misty
Maslowski Eric C
Monteiro André
Vincent Maurice
Zubieta Jon-Kar
DaSilva Alexandre F
Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
Molecular Pain
Trigeminal Neuropathic Pain
Opioid system
Neuroplasticity
Chronic pain
Positron emission tomography
title Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
title_full Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
title_fullStr Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
title_full_unstemmed Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
title_short Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: A pilot study
title_sort reduced basal ganglia μ opioid receptor availability in trigeminal neuropathic pain a pilot study
topic Trigeminal Neuropathic Pain
Opioid system
Neuroplasticity
Chronic pain
Positron emission tomography
url http://www.molecularpain.com/content/8/1/74
work_keys_str_mv AT dossantosmarcos reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT martikainenilkka reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT nascimentothiago reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT lovetiffanym reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT deboermisty reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT maslowskiericc reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT monteiroandre reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT vincentmaurice reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT zubietajonkar reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy
AT dasilvaalexandref reducedbasalgangliamopioidreceptoravailabilityintrigeminalneuropathicpainapilotstudy